Adaptimmune has appointment Rafael Amado as Chief Medical Officer and Adrian Rawcliffe as Chief Financial Officer.
Both appointments are effective from 16 March.
Adaptimmune strengthens management team
Adaptimmune has appointment Rafael Amado as Chief Medical Officer and Adrian Rawcliffe as Chief Financial Officer. Both appointments are effective from 16 March.
Tags
Related posts
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
